SamanthaLeeIrwinMDMSc; FRCPC

Child Neurology • Austin, TX

Associate Professor of Clinical Neurology. Pediatric Headache Fellowship Director.

Join to view full profile

Dr. Irwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Irwin's full profile

Already have an account?

Office
4910 Mueller Blvd
Ste 300
Austin, TX 78723
Phone+1 512-628-1855

Fax+1 512-380-7544

Education & Training

University of California (San Francisco)Fellowship, Headache Medicine, 2017 - 2018
University of Toronto, The Hospital for Sick Children. FRCPC, Child Neurology, 2012 - 2017
University of Dublin, Trinity CollegeClass of 2012
Maastricht UniversityMSc, Neuropsychology, 2006 - 2007
Dalhousie UniversityBSc, Neuroscience, 2002 - 2006

Certifications & Licensure

TX State Medical License 2023 - 2026
CA State Medical License 2017 - 2025
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Publications & Presentations

PubMed

33 citations
Decreased Number of Self-Paced Saccades in Post-Concussion Syndrome Associated with Higher Symptom Burden and Reduced White Matter Integrity
Foad Taghdiri, Jonathan Chung, Samantha L. Irwin, Namita Multani, Apameh Tarazi
Journal of Neurotrauma. 2017-12-14
5 citations
Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.
Amy A Gelfand, I Elaine Allen, Barbara Grimes, Samantha Irwin, William Qubty
Headache. 2023-10-01
33 citations
Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.
Kaitlin Greene, Carlyn Patterson Gentile, Christina L. Szperka, Marcy Yonker, Amy A. Gelfand
Pediatric Neurology. 2021-01-01

Press Mentions

A New Option for Young Migraine SufferersJuly 14th, 2021
Study Compares Nerivio® to Standard Care Medications for Acute Treatment of Migraine in AdolescentsJune 30th, 2021